Back to Newsroom

HIV Researchers Seek a Potential Cure

Academic institutes, including Seattle BioMed, are developing vaccines that will elicit antibodies against conserved sites among all HIV variants. Dr. Stamatatos says four conserved regions have been identified. “Ideally, we want to elicit antibodies against all four.” How, exactly, remains the question. Seattle BioMed and Scripps Research Institute have new leads. Dr. Stamatatos says corporate involvement is necessary to rapidly test these new vaccines.